Business Context and Reporting Period
This Form 8-K is a current report filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on September 7, 2023. The registrant is a Delaware corporation with principal executive offices in Palo Alto, California. The report addresses a regulatory notice regarding the continued listing of its common stock (trading symbol: ATNF) and warrants (trading symbol: ATNFW) on The Nasdaq Capital Market.
Key Financial Metrics
This filing is a notice of a listing deficiency and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The material event reported is the receipt of a Notification Letter from Nasdaq on September 7, 2023. The Company failed to maintain the minimum bid price requirement of $1.00 per share for 30 consecutive business days (July 26, 2023, to September 6, 2023). This deficiency triggers a compliance period but does not immediately impact the Company's listing status.
Guidance, Outlook, and Risks
- Compliance Timeline: The Company has 180 calendar days, until March 5, 2024, to regain compliance.
- Compliance Criteria: To regain compliance, the common stock must close at or above $1.00 per share for a minimum of 10 consecutive business days.
- Contingencies: If compliance is not met by the initial deadline, the Company may be granted an additional 180 days if it meets initial listing criteria and notifies Nasdaq of its intent to cure the deficiency, potentially via a reverse stock split.
- Delisting Risk: Failure to qualify for or meet the requirements of the second compliance period will result in delisting, subject to an appeal process.
- Management Commentary: Management intends to monitor the closing bid price and may consider available options, including a reverse stock split, to regain compliance.
Investor Verification Checklist
- Verify the current trading price of ATNF to assess the likelihood of meeting the $1.00 threshold within the compliance window.
- Monitor future filings for announcements regarding a potential reverse stock split.
- Review the Company's most recent 10-K or 10-Q for actual financial health metrics, as this 8-K contains no financial data.
- Confirm the exact date of the 10-day compliance window once the stock price stabilizes above $1.00.